Greytown Advisors Inc. Bristol Myers Squibb CO Transaction History

Greytown Advisors Inc.

$169 Million
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$57.89 - $64.73 $69,931 - $78,193	-1,208 Reduced 23.47%	3,938 $228,000
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $162,205 - $180,104	-2,546 Reduced 33.1%	5,146 $329,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $6,308 - $7,154	-96 Reduced 1.23%	7,692 $533,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $55,400 - $65,601	-809 Reduced 9.41%	7,788 $560,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $309 - $182,725	-2,378 Reduced 21.67%	8,597 $611,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $225,122 - $247,938	-3,100 Reduced 22.02%	10,975 $851,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $315,699 - $378,552	-5,135 Reduced 26.73%	14,075 $1.04 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $150,753 - $175,743	-2,811 Reduced 12.77%	19,210 $1.2 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $60,235 - $70,557	-1,018 Reduced 4.42%	22,021 $1.31 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $403,838 - $439,780	6,523 Added 39.5%	23,039 $1.54 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $235,401 - $264,757	3,967 Added 31.61%	16,516 $1.05 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $45,152 - $51,166	782 Added 6.65%	12,549 $785,000
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $141,966 - $157,318	2,472 Added 26.59%	11,767 $709,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $230,572 - $269,562	-4,206 Reduced 31.15%	9,295 $547,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $212,140 - $308,289	-4,572 Reduced 25.3%	13,501 $753,000
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $7,873 - $10,270	-160 Reduced 0.88%	18,073 $1.16 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $53,676 - $63,641	1,255 Added 7.39%	18,233 $925,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $55,373 - $61,230	1,241 Added 7.89%	16,978 $770,000
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $90 - $107	-2 Reduced 0.01%	15,737 $751,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $19,942 - $25,861	409 Added 2.67%	15,739 $818,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $177,711 - $200,445	-3,220 Reduced 17.36%	15,330 $952,000
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $34,511 - $43,015	683 Added 3.82%	18,550 $1.03 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $53,268 - $61,323	889 Added 5.24%	17,867 $1.13 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $67,072 - $73,126	1,119 Added 7.06%	16,978 $1.04 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $875,892 - $1.01 Million	15,859	15,859 $1.01 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greytown Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greytown Advisors Inc. with notifications on news.

Account